Loading chat...
NJ A2587
Bill
Status
1/9/2024
Primary Sponsor
Jessica Ramirez
Click for details
AI Summary
-
Prohibits drug manufacturers, pharmacies, wholesalers, and medication supply intermediaries from entering agreements with healthcare practitioners to dispense drugs via devices or kiosks that steer patients to specific pharmacies or restrict pharmacy choice
-
Requires practitioners using prescription dispensing devices to either obtain voluntary patient consent for transmitting information to a specific pharmacy, or provide full disclosure of the transmission with notice of the patient's right to choose their own pharmacy
-
Establishes civil penalties for steering violations: minimum $100,000 for first offense, $200,000 for second, and $400,000 for subsequent violations by manufacturers/pharmacies; $250-$1,000 escalating penalties for practitioners
-
Prohibits prescription dispensing devices from using patient medical information for marketing or selling it to promote specific pharmacies or medications without HIPAA-compliant authorization under 45 C.F.R. s.164.508
-
Requires dispensing devices to notify patients of any insurance charges related to transmitting their medical information and any benefits they may receive from using the system
Legislative Description
Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.
Health
Last Action
Introduced, Referred to Assembly Health Committee
1/9/2024